Trupanion (NASDAQ:TRUP) Given New $34.00 Price Target at Canaccord Genuity Group

Trupanion (NASDAQ:TRUPFree Report) had its price objective lowered by Canaccord Genuity Group from $40.00 to $34.00 in a report issued on Friday morning, Benzinga reports. The firm currently has a buy rating on the financial services provider’s stock.

Several other research analysts have also recently commented on TRUP. Stifel Nicolaus upped their target price on shares of Trupanion from $25.00 to $28.00 and gave the stock a hold rating in a research report on Friday, February 16th. Piper Sandler lowered their target price on Trupanion from $28.00 to $22.00 and set a neutral rating on the stock in a research report on Friday. Finally, Evercore ISI reduced their price target on Trupanion from $35.00 to $31.00 and set an outperform rating for the company in a research report on Tuesday, February 20th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Trupanion presently has a consensus rating of Hold and a consensus target price of $29.40.

Get Our Latest Report on TRUP

Trupanion Price Performance

Shares of TRUP opened at $20.00 on Friday. Trupanion has a 12 month low of $18.45 and a 12 month high of $36.66. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.62 and a quick ratio of 1.63. The stock has a fifty day moving average price of $25.61 and a 200 day moving average price of $26.72. The company has a market cap of $839.80 million, a P/E ratio of -31.02 and a beta of 1.76.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.02. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.03%. The company had revenue of $306.12 million during the quarter, compared to the consensus estimate of $300.51 million. During the same quarter in the previous year, the company posted ($0.60) earnings per share. The company’s revenue for the quarter was up 19.4% compared to the same quarter last year. On average, research analysts forecast that Trupanion will post -0.43 earnings per share for the current year.

Institutional Investors Weigh In On Trupanion

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Texas Permanent School Fund Corp boosted its stake in Trupanion by 1.8% during the 1st quarter. Texas Permanent School Fund Corp now owns 31,269 shares of the financial services provider’s stock valued at $863,000 after purchasing an additional 561 shares in the last quarter. GSA Capital Partners LLP boosted its stake in Trupanion by 376.5% during the first quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider’s stock valued at $2,210,000 after buying an additional 63,247 shares in the last quarter. Capstone Investment Advisors LLC acquired a new position in Trupanion during the first quarter worth about $269,000. Check Capital Management Inc. CA raised its position in Trupanion by 34.8% in the first quarter. Check Capital Management Inc. CA now owns 32,355 shares of the financial services provider’s stock worth $893,000 after acquiring an additional 8,355 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Trupanion in the 4th quarter valued at about $31,398,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.